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Recruitment of TNF Receptor 1 to Lipid Rafts
Is Essential for TNF-Mediated NF-B Activation
of TNFR1 leads to the recruitment of the death domain
(DD)-containing adaptor molecule TNFR1-associated
death domain protein (TRADD), which serves as a plat-
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receptor-associated factor 2 (TRAF2). This TRADD-RIP-CH-1066 Epalinges
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et al., 1998; Liu et al., 1996; Ting et al., 1996). TNFR1 canDepartment of Biology
also recruit caspase-8 via TRADD and Fas-associatedUniversity of Konstanz
death domain protein (FADD/MORT1) to induce the sig-Universita¨tsstrasse 10
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Binding of FasL induces receptor activation resultingGermany
in the recruitment of several signaling molecules to the
DD present in its cytoplasmic region (Aravind et al.,
2001; Ashkenazi and Dixit, 1998; Budd, 2001; Krammer,Summary
2000). The DD of Fas (CD95) interacts with the DD of the
adaptor FADD. This interaction unmasks the N-terminalEngagement of TNF receptor 1 by TNF activates the
death effector domain of FADD allowing the recruitmenttranscription factor NF-B but can also induce apopto-
of procaspase-8 and caspase-10, which are autoproteo-sis. Here we show that upon TNF binding, TNFR1
lytically cleaved, leading to the assembly of the maturetranslocates to cholesterol- and sphingolipid-enriched
enzyme. Active caspase-8 and -10 subsequently cleavemembrane microdomains, termed lipid rafts, where it
downstream caspases to initiate apoptosis (Aravind etassociates with the Ser/Thr kinase RIP and the adaptor
al., 2001; Ashkenazi and Dixit, 1998; Budd, 2001; Kram-proteins TRADD and TRAF2, forming a signaling com-
mer, 2000).plex. In lipid rafts, TNFR1 and RIP are ubiquitylated.
Binding of agonistic antibodies (Ab) or ligand to FasFurthermore, we provide evidence that translocation
or TNFR was demonstrated to cause receptor clusteringto lipid rafts precedes ubiquitylation, which leads to
at the cell surface (Dhein et al., 1992; Natoli et al., 1998).the degradation via the proteasome pathway. Inter-
Such clustering has been observed for a variety of differ-fering with lipid raft organization not only abolishes
ent receptors, and the fact that, upon stimulation, certainubiquitylation but switches TNF signaling from NF-
proteins involved in cell signaling are specifically re-B activation to apoptosis. We suggest that lipid rafts
cruited to or sequestered from microdomains has ledare crucial for the outcome of TNF-activated signal-
to the idea that these lipid rafts serve as platforms foring pathways.
cellular signaling (Brown and London, 1998, 2000; Riet-
veld and Simons, 1998; Sedwick and Altman, 2002; SimonsIntroduction
and Toomre, 2000). Lipid rafts are enriched in sphingoli-
pids and cholesterol, which pack tightly against the sat-Members of the tumor necrosis factor (TNF) family and
urated hydrocarbon chains of certain lipids (Brown andtheir respective receptors play pivotal roles in the orga-
London, 2000). The role of microdomains in signal trans-
nization and function of the immune system. In addition,
duction emanating from members of the TNFR family
there is growing evidence that dysregulated TNF expres-
has not been addressed until recently. Investigations,
sion and/or signaling are implicated in various diseases, however, have produced ambiguous results. Fas was
such as multiple sclerosis, Alzheimer’s disease, and reported to be excluded from microdomains (Gajate and
rheumatoid arthritis (Balkwill et al., 2000). A subfamily Mollinedo, 2001; Ko et al., 1999), and Fas signaling was
of TNF ligands, including TNF and Fas ligand (FasL), not inhibited by the destruction of lipid rafts (Algeciras-
are potent inducers of apoptosis (Aravind et al., 2001; Schimnich et al., 2002). In contrast, Fas was also shown
Ashkenazi and Dixit, 1998; Baker and Reddy, 1998; Baud to be constitutively associated with lipid rafts (Hueber
and Karin, 2001; Budd, 2001; Krammer, 2000; Locksley et al., 2002) and to require ceramide-rich microdomains
et al., 2001). In the case of TNF, however, activation for signal transduction (Cremesti et al., 2001; Grassme
of transcription factors such as NF-B, which drives the et al., 2001a).
synthesis of a number of proinflammatory gene prod- Similarly, discrepancies exist regarding the localiza-
ucts (Baker and Reddy, 1998; Baud and Karin, 2001; tion of TNFR1 in lipid rafts. TNFR1 was reported to local-
Locksley et al., 2001) and antiapoptotic proteins (Mi- ize exclusively in lipid rafts of unstimulated U937 cells. In
cheau et al., 2001; Wang et al., 1998), is more commonly addition, under lipoprotein-deficient conditions, TNFR1
observed. surface expression and consequently TNF-mediated
TNF exerts its functions through two distinct recep- apoptosis was reduced (Ko et al., 1999). In contrast,
tors, TNFR1 (CD120a) and TNFR2 (CD120b). Activation partitioning of TNFR1 in lipid rafts of fibroblasts was
only observed upon TNF activation (Veldman et al.,
2001). Furthermore, TNF stimulation was shown to in-*Correspondence: daniel.legler@uni-konstanz.de
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crease a neutral sphingomyelinase activity in nonraft
compartments. More recently, the DD of TNFR1 was
reported to be required for partial localization of TNFR1
variants in microdomains of unstimulated HeLa cells
(Cottin et al., 2002).
We therefore reinvestigated the role of lipid rafts in
TNF and FasL signaling. We show that lipid rafts play
an essential role in TNF-mediated NF-B activation but
not in FasL-induced cell death. Upon activation, TNFR1
but not Fas translocates to lipid rafts, where it binds to
various signaling proteins, forming a receptor-induced
signaling complex. We also show that the specific en-
gagement of the receptor in lipid rafts induces ubiqui-
tylation of both TNFR1 and RIP, providing evidence for
a potential role of lipid rafts in the degradation of the
signaling complex. Finally, we propose that the disrup-
Figure 1. Constitutive Partitioning of TNFR1 in Lipid Raftstion of lipid rafts blocks NF-B activation and hence
HT1080 fibrosarcoma cells were lysed in 1% Triton X-100 and sub-sensitizes cells for apoptosis.
jected to sucrose density gradient centrifugation to isolate lipid
rafts. Proteins from equal volume of representative collected frac-
Results tions were separated by SDS-PAGE and analyzed by Western blot-
ting using specific Ab against TNFR1, Fas, EGFR, Fyn, and
caveolin-1. To analyze the distribution of GM1, 2 l of each fractionTNFR1 but Not Fas Is Recruited to Lipid Rafts
was dot blotted onto a nitrocellulose membrane and detected usingupon Engagement
CTxHRP.In order to investigate whether lipid rafts are involved
in TNF- and FasL-mediated clustering of their recep-
tors and initiation of the respective signal transduction
population was independent of TNF triggering and waspathway, the plasma membrane localization of endoge-
not observed upon shorter exposure of the same experi-nous TNFR1 and Fas was first examined on resting hu-
ment (data not shown). In addition, the same unspecificman fibrosarcoma HT1080 cells. Both TNFR1 and Fas
fuzziness was also observed in the heavy fractions ofwere expressed at the cell surface, whereas TNFR2 was
the sucrose gradient depicted in Figure 1 upon longernot detectable by FACS analysis (data not shown). The
exposure (data not shown). In contrast, FADD and cas-latter characteristic was further confirmed by the inabil-
pase-8, which are involved in the apoptotic pathway,ity of TNFR2-specific Ab to inhibit the TNF-mediated
were not found in lipid rafts upon TNF stimulation (Fig-death of HT1080 cells rendered susceptible to apoptosis
ure 2A). Finally, upon triggering of HT1080 cells withby expressing a mutated IB (data not shown and Mi-
FasL, neither Fas nor any of the molecules involved incheau et al., 2001). Lipid rafts were isolated by discontin-
the early steps of the apoptotic signaling pathway, suchuous sucrose density gradients of Triton-X 100 cell ly-
as FADD and caspase-8, translocated to lipid rafts (Fig-sates and were found in light fractions enriched in the
ure 2B). The absence of raft translocation was not duelipid raft markers glycosphingolipid GM1, caveolin-1,
to inefficient Fas signals, as procaspase-8 was progres-and the Src kinase Fyn (Figure 1). Although a small
sively processed after 20 min of FasL stimulation leadingamount of TNFR1 was found within lipid rafts, the large
to apoptosis.majority of the receptor was excluded from microdo-
mains, together with the epidermal growth factor (EGF)
receptor (Figure 1). Moreover, Fas was completely ab- The TNF Signaling Complex Is Predominantly
Found in Lipid Raftssent from lipid rafts (Figure 1).
Association of TNFR1 with lipid rafts was greatly in- Next, we investigated the TNFR1 and Fas signal trans-
duction pathways by means of analysis of their signalingcreased upon receptor engagement (Figure 2A). A signif-
icant translocation was already observed as early as 2 complexes. Additionally, we studied whether the signal-
ing complex elicited by the engagement of endogenousmin after TNF addition and progressively declined after
10 min of stimulation down to its initial distribution in TNFR1 occurred within or outside of microdomains. To
this end, HT1080 cells were stimulated with Flag-taggedresting cells after 60 min. Early events occurring after
TNFR1 activation are the recruitment of the adaptors soluble TNF, lipid rafts were isolated, and engaged
receptors including the signaling complexes were im-TRADD and TRAF2, as well as the kinases RIP, IKK,
and IKK. All these proteins translocated to microdo- munoprecipitated using an anti-Flag Ab. As depicted in
Figure 3A, the majority of engaged TNFR1 was foundmains after 2 to 10 min of TNF stimulation (Figure 2A).
Lipid raft association of the receptor, as well as of the in lipid rafts after 2 min of stimulation, and lipid raft-
associated TNFR1 was modified. In contrast, engagedrecruited signaling molecules, was transient and ceased
after prolonged receptor triggering. Interestingly, raft TNFR1 molecules that were excluded from microdo-
mains did not display such a modification. This differ-translocation of TNFR1 and RIP was accompanied by
modifications of both proteins as they migrated with ence was even more striking for RIP, which was maxi-
mally recruited to the raft-associated signaling complexhigher apparent molecular weights on SDS-PAGE (Fig-
ure 2A). The fuzziness of the band obtained by the elec- after 2 min of TNF stimulation where it was found al-
most exclusively in its modified forms (Figure 3A). Thetrophoretic separation of the Triton X-100 soluble TNFR1
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Figure 2. TNF Stimulation Recruits Signal-
ing Molecules to Lipid Rafts
HT1080 cells were stimulated with TNF (A)
or FasL (B) for the indicated time points, and
Triton X-100 soluble (S) and insoluble lipid
raft (R) fractions were isolated. Equal aliquots
of the fractions were subjected to SDS-PAGE,
and the protein distribution was assessed
by Western blotting using specific Ab against
TNFR1 (A) or Fas (B), TRADD, RIP, TRAF2,
IKK, IKK, FADD, caspase-8, and caveolin-1.
same pattern of modification was also observed upon confirms the recent demonstration of the interaction
between caveolin-1 and TRAF2 (Feng et al., 2001).TNF stimulation of Jurkat T cells, myeloid leukemia
U937 cells (data not shown), and HeLa cells (Chen et In contrast, FasL-mediated engagement of its recep-
tor did not induce the translocation into lipid rafts ofal., 2002; Zhang et al., 2000). Similarly, most of TRADD
and TRAF2 recruited to the engaged TNFR1 were found HT1080 cells of Fas or of any of the components of the
Fas signaling complex (Figure 3B).in lipid rafts. Also, TRADD was modified upon TNF
stimulation, but modified species were found in both
Triton X-100 soluble and insoluble fractions. Under TNFR1 and RIP Are Ubiquitylated in Lipid Rafts
Protein modifications are important means of regulatingthese conditions, however, we failed to detect members
of the IB kinase (IKK) complex with the engaged their function, activity, or localization (Muller et al., 2001).
Since ubiquitylation has been shown to play a role inTNFR1, suggesting that these molecules, coimmuno-
precipitated with the engaged TNFR1, are loosely bound receptor internalization and degradation, the modifica-
tion observed for TNFR1 and RIP may be the additionto the complex and are released during the raft isolation
procedure (data not shown and see below). Comparable of ubiquitin. To test this possibility, HT1080 cells were
stimulated for 30 min with TNF in the presence of theresults on the recruitment and modification of signaling
molecules were obtained upon stimulation of HT1080 proteasome inhibitor lactacystin. This treatment re-
sulted in a significant accumulation of modified TNFR1cells with an anti-TNFR1 Ab instead of TNF (data not
shown). These results provide evidence that, upon and RIP in the raft-associated signaling complex,
whereas, in the absence of lactacystin, the amount ofTNFR1 engagement, the signaling complex was formed
and immediately translocated to lipid rafts, where both modified species decreased after prolonged stimulation
(Figure 4A). This result suggests that both proteins areTNFR1 and RIP were modified. Consistent with previous
data (Wallach et al., 1999), FADD and caspase-8 were ubiquitylated and subsequently degraded via the pro-
teasome. To further verify whether engaged TNFR1 andnot found in the membrane-associated TNF signaling
complex (Figure 3A). Moreover, after 2 to 10 min of TNF recruited RIP were indeed ubiquitylated, we transfected
HT1080 cells with HA-tagged ubiquitin. Western blotstimulation, the signaling complex contained the lipid
raft-resident caveolin-1 (Figure 3A), an observation that analysis of the immunoprecipitated TNF signaling com-
Figure 3. Accumulation of the TNF-Induced
Signaling Complex in Lipid Rafts
HT1080 cells were stimulated with Flag-
tagged TNF (A) or Flag-tagged FasL (B) for
the indicated time points, and Triton X-100
soluble (S) and insoluble lipid raft (R) fractions
were isolated. Engaged receptors and their
signaling complexes were immunoprecipi-
tated using anti-Flag Ab. For comparison, the
total amount of receptor was immunoprecipi-
tated by adding the ligand and anti-Flag Ab to
the soluble and raft fractions of unstimulated
cells. Immunoprecipitates and correspond-
ing total cell lysates were subjected to SDS-
PAGE and immunobloted using specific Ab.
Immunity
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of ubiquitylated molecules using an anti-ubiquitin Ab.
Subsequent immunoblotting using specific Ab clearly
revealed that both TNFR1 and RIP but not TRADD and
TRAF2 were exclusively ubiquitylated in lipid rafts upon
TNF stimulation (Figure 4C).
Lipid Rafts Are Essential for Ubiquitylation,
and Translocation Precedes Ubiquitylation
Since the TNF signaling complex and ubiquitylation
were found predominantly in lipid rafts, we investigated
the role of microdomains in the formation of the signaling
complex and in the protein modifications. To address
this question, we treated HT1080 cells with dipalmitoyl
phosphatidylethanolamine (DPPE), a phospholipid that
we have previously shown to partition preferentially into
lipid rafts, thus selectively blocking the recruitment of
the T cell receptor signaling complex to microdomains
without altering their structure (Legler et al., 2001). Thus,
in HT1080 cells pretreated with DPPE prior to TNF
stimulation, the majority of the engaged receptor re-
mained in the Triton X-100 soluble fraction (Figure 5A),
demonstrating that DPPE blocked TNF-induced trans-
location of TNFR1 to lipid rafts. Moreover, in DPPE-
treated cells, only a reduced amount of RIP was recruited
to the engaged receptor, and receptor-associated RIP
was found predominantly in the nonraft fraction (Figure
5A), indicating that DPPE inhibited the translocation to
lipid rafts of the entire signaling complex. Strikingly,
both TNFR1 and RIP were not modified in DPPE-treated
cells. In contrast, the lipid analog DOPE, which differs
from DPPE only by having unsaturated oleic acid in
place of saturated palmitic acid and which does not
partition in lipid rafts (Legler et al., 2001), had no appar-
ent effect on the recruitment of TNFR1 to lipid rafts, the
assembly of the signaling complex, and on the ubiqui-
tylation of TNFR1 and RIP (Figure 5A). These data sup-
port the notion that lipid rafts are critical for the stabiliza-Figure 4. TNF-Induced TNFR1 and RIP Ubiquitylation in Lipid
Rafts tion/assembly of the TNFR1-associated signaling
(A) HT1080 cells were incubated or not with the proteasome inhibitor complex and that ubiquitylation takes place in lipid rafts.
lactacystin (LC) for 30 min, followed by stimulation with TNF for 2 To corroborate these findings, HT1080 cells were
or 30 min. TNF-induced signaling complexes from Triton X-100 treated with methyl--cyclodextrin (MCD), which dis-
soluble (S) and insoluble lipid raft (R) fractions were isolated and rupts lipid rafts by specific cholesterol depletion (Harderanalyzed as in Figure 3.
et al., 1998; Janes et al., 1999). As shown in Figure(B) HT1080 cells were transiently transfected with HA-tagged ubiqui-
5B, in MCD-treated cells, TNF triggering induced thetin, and TNFR1-associated signaling complexes were isolated 2 and
10 min after stimulation. Ubiquitylated proteins of TNF-induced recruitment of RIP to engaged TNFR1 in the nonraft
signaling complexes were revealed by immunoblotting using an anti- fraction, and ubiquitylation of both TNFR1 and RIP was
HA Ab. abolished. In order to test whether MCD treatment inter-
(C) HT1080 cells were stimulated with TNF, and the engaged recep- fered with the association of other signaling moleculestors from Triton X-100 soluble (S) and insoluble lipid raft (R) fractions
recruited to engaged TNFR1, cells were lysed in Brij78,were immunoprecipitated using an anti-Flag Ab. The signaling com-
a nonionic detergent with dispersing properties for bothplexes were dissociated by boiling in SDS, followed by immunopre-
cipitation using an anti-ubiquitin Ab. Engaged and ubiquitylated lipid raft- and nonraft-associated molecules. Specific
proteins were analyzed by Western blotting using Ab against TNFR1, immunoprecipitations of engaged TNFR1 from such cell
TRADD, RIP, and TRAF2. lysates coimmunoprecipitated RIP, as well as IKK and
IKK. In contrast, MCD-mediated disruption of lipid rafts
completely abolished the recruitment of the IKK com-plex using anti-HA Ab revealed the presence of ubiqui-
tylated proteins with apparent molecular weights corre- plex to the triggered TNFR1 (Figure 5C). In control exper-
iments designed to test the perturbing effect of MCD onsponding to those of TNFR1 (55–70 kDa) and RIP (80–100
kDa) in the signaling complex of microdomains (Figure the membrane raft structure, HT1080 cells were labeled
with 14C cholesterol, and the distribution of cholesterol4B). A more direct demonstration that the two ubiqui-
tylated molecular species corresponded to TNFR1 and was analyzed after lipid raft isolation. As shown in Fig-
ure 5D, MCD efficiently depleted cholesterol from theRIP was obtained by immunoprecipitation of the signal-
ing complex by TNF, followed by the dissociation of Triton X-100 insoluble lipid raft but not from the soluble
fraction.the complex by boiling in SDS, and immunoprecipitation
Essential Role of Lipid Rafts for TNF Signaling
659
Figure 6. Blocking Lipid Rafts Inhibits TNF-Mediated NF-B Acti-
vation and Sensitizes for Apoptosis
(A) Wild-type (wt) or IB mutant (IB mut) HT1080 cells were pre-
treated or not with MCD, DPPE, or DOPE for 30 min, washed, and
stimulated with TNF or FasL as indicated. Cell lysates were sub-
jected to immunoblotting, and NF-B activation was monitored by
the phosphorylation of IB. The same blot was reprobed using an
Ab against total IB as internal control for protein loading.
(B) Wild-type or IB mutant HT1080 cells were pretreated or not
with MCD, DPPE, or DOPE, following stimulation with TNF or FasL
for 90 min. Viable cells were then washed and quantified 36 hr later,Figure 5. Lipid Rafts Are Essential for Ubiquitylation, and Transloca-
and the percentage of apoptotic cells was calculated.tion Precedes Ubiquitylation
(A) HT1080 cells were pretreated with DPPE or DOPE, respectively,
for 30 min and stimulated with TNF, and immunoprecipitated Interfering with the Lipid Raft Composition Induces
TNFR1 and RIP of the engaged signaling complex from Triton X-100
the Switch of TNF-Mediated Signaling Pathwaysoluble (S) and insoluble lipid raft (R) fractions were analyzed by
from NF-B Activation to ApoptosisWestern blotting.
Recruitment of TRADD, RIP, and TRAF2 to the TNF(B) HT1080 cells were pretreated or not with MCD for 30 min prior
to TNF stimulation for 2 and 10 min. TNFR1 and RIP of the signaling signaling complex mediates IB kinase and subse-
complexes from Triton X-100 soluble and insoluble raft fractions quent NF-B activation (Baldwin, 1996; Karin and Ben-
were analyzed. Neriah, 2000). The NF-B activity is regulated by inhibitor
(C) HT1080 cells were treated or not with MCD, stimulated with
proteins (IBs), which retain the transcription factor inTNF for the indicated time points, and lysed in 0.5% Brij 78 for 2
the cytoplasm. Upon TNF triggering, IBs becomehr followed by immunoprecipitation of the engaged TNFR1 using
phosphorylated by the IKK complex, resulting in theiranti-Flag Ab; the engaged signaling complex was analyzed by West-
ern blotting. ubiquitylation and subsequent degradation by the pro-
(D) HT1080 cells were labeled with 14C cholesterol and treated or teasome, liberating NF-B for translocation into the nu-
not with MCD, and the distribution of 14C cholesterol was measured cleus. In order to analyze NF-B activation, we moni-
in Triton X-100 soluble and insoluble lipid raft fractions.
tored the phosphorylation of IB. TNF-induced
phosphorylation of IBwas observed 2 min after stimu-
lation of HT1080 cells, whereas FasL stimulation had no
effect (Figure 6A). We next investigated the role of lipid
Immunity
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rafts in TNF-mediated NF-B activation. As demon- (Cottin et al., 2002) and the finding that TNF stimulation
resulted in a partial shift of TNFR1 to caveolin-enrichedstrated in Figure 6A, disruption of lipid rafts by MCD-
membrane microdomains in fibroblasts (Veldman et al.,mediated cholesterol depletion completely abrogated
2001). However, in the latter study, TNFR1 was not de-TNF-induced phosphorylation of IB. Similarly, DPPE
tected in lipid rafts of resting fibroblasts (Veldman etthat blocks activation-induced recruitment of signaling
al., 2001), whereas in U937 and NIH-3T3 cells TNFR1molecules to lipid rafts (Legler et al., 2001) also impaired
localized exclusively in caveolin-like domains even with-IB phosphorylation (Figure 6A). In contrast, the non-
out TNF triggering (Ko et al., 1999). Interestingly, theraft lipid analog DOPE had no apparent effect on
death domain of TNFR1 seems to be necessary andTNF-mediated NF-B activation. Under these condi-
sufficient to target its receptor to lipid rafts (Cottin ettions, both MCD and DPPE treatment did not affect the
al., 2002).cell viability (see below). In control experiments (Figure
The functional importance of lipid rafts in TNF-medi-6A), TNF-induced IB phosphorylation was not de-
ated signal transduction is still poorly understood. Cul-tected in IB mutant HT1080 cells, which express a
turing of U937 cells under lipoprotein-deficient condi-modified form of the NF-B inhibitor IB that cannot
tions reduced the surface expression of both CD36 andbe degraded due to mutated phosphorylation sites (Mi-
TNFR1. Cholesterol depletion under these conditionscheau et al., 2001).
blocked TNF-induced apoptosis (Ko et al., 1999).Cell death induced by TNF family members is tightly
Moreover, the study of sphingomyelinase activities as-regulated by genes that are activated by NF-B, and
sociated with fibroblast caveolae revealed that TNFmodulation of the responses in favor of NF-B protects
stimulation activated a pool of the neutral sphingomyeli-cells from apoptosis. Stimulation with TNF, contrary
nase localized outside of lipid rafts (Veldman et al.,to FasL, did not induce apoptosis of HT1080 cells (Figure
2001). Here we demonstrate that the TNF-induced sig-6B). However, interfering with lipid rafts not only blocked
naling complex, consisting of TRADD, RIP, and TRAF2,TNF-mediated NF-B activation, but MCD- and DPPE-
was predominantly found in lipid rafts, whose integritytreated HT1080 cells also became susceptible to
is required for the activation of the NF-B pathway (Fig-TNF-mediated cell killing (Figure 6B). Disruption of lipid
ure 3). In fact, disruption of lipid rafts by cholesterolrafts by MCD provoked TNF-induced apoptosis of 31%
depletion with MCD totally blocked TNF-inducedof wild-type HT1080 cells. Similarly, 28% of TNF-stimu-
NF-B activation by interfering with the recruitment oflated cells died after saturation of lipid rafts by DPPE,
the IKK complex to the engaged TNFR1 (Figures 5 andwhereas DOPE treatment had no effect. For comparison,
6). This result was confirmed when lipid rafts were satu-41% of IB mutant HT1080 cells, which are unable to
rated by exogenous insertion of DPPE into the cell mem-activate the NF-B pathway and to synthesize antiapo-
brane. DPPE partitions preferentially in sphingolipid/ptotic proteins such as FLIP, TRAFs, and IAPs (Micheau
cholesterol-enriched microdomains and, unlike MCD,et al., 2001; Wang et al., 1998), underwent apoptosis
does not affect the integrity, the protein composition,when treated with TNF (Figure 6B). On the other hand,
and the ability to form clusters of lipid rafts, but inhibitsFasL-mediated apoptosis of HT1080 cells was efficiently
activation-induced recruitment of signaling moleculesinduced, irrespective of lipid raft integrity (Figure 6B).
to microdomains (Legler et al., 2001). Moreover, both
types of reagents rendered a significant number of
Discussion
HT1080 cells susceptible to TNF-induced apoptosis,
in a manner comparable to cells expressing a modified
The crucial role of lipid rafts in signal transduction of repressor form of the NF-B inhibitor IB (Figure 6).
several receptors, such as TCR, BCR, and FcRs, has These findings are consistent with recently published
been well documented (Brown and London, 1998, 2000; observations showing that inhibition of NF-B activation
Rietveld and Simons, 1998; Sedwick and Altman, 2002; renders cells sensitive to TNF-mediated killing by
Simons and Toomre, 2000). Whether signals induced by blocking NF-B-dependant de novo synthesis of sur-
TNFR family members also depends on these special- vival factors such as FLIP, TRAFs, and IAPs (Micheau
ized membrane microdomains has not been analyzed in et al., 2001; Wang et al., 1998). It is therefore tempting
detail or has revealed contradicting results, in particular to speculate that, in raft-depleted/inactivated cells, a
concerning the membrane localization of TNFR1 (Cottin similar mechanism is responsible for the switch in the
et al., 2002; Ko et al., 1999; Veldman et al., 2001) and TNF-induced signal transduction pathway from NF-B
Fas (Algeciras-Schimnich et al., 2002; Cremesti et al., activation toward cell death (Figure 7). It is well known
2001; Gajate and Mollinedo, 2001; Grassme et al., 2001a, that the TNFR1-TRADD-RIP-TRAF2 complex initiates
2001b; Hueber et al., 2002; Ko et al., 1999). the pathway leading to NF-B activation, while the
In the present study we therefore investigated the role TNFR1-TRADD-FADD complex initiates the pathway
of lipid rafts in signal transduction events of Fas and leading to apoptosis (Hsu et al., 1996). However, we
TNFR1, two members of the TNFR family expressed at were not able to detect FADD in the TNFR1 signaling
the surface of the human fibrosarcoma cell line HT1080, complex after MCD treatment (data not shown), indicat-
which was found suitable for this study since it does ing that additional mechanisms are responsible for mod-
not express TNFR2 as assessed by FACS as well as by ifying the outcome of TNF signaling.
functional analysis. Although a small amount of TNFR1 Contradictory results have also been published on the
constitutively localized in microdomains of HT1080 role of lipid rafts in Fas signaling. In one report, Fas was
cells, we found that, upon TNF triggering, TNFR1 trans- found to partition constitutively in lipid rafts of thymo-
located to lipid rafts. This is in agreement with the local- cytes and the B cell line SKW6.4 (Hueber et al., 2002).
In other studies, only engaged Fas was shown to colo-ization of TNFR1 in nonactivated, transfected HeLa cells
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Figure 7. Lipid Rafts Are Essential for
TNF-Induced TNFR1 and RIP Ubiquitylation;
Blocking Lipid Rafts Switches from NF-B
Activation to Apoptosis
In resting human HT1080 fibrosarcoma cells,
TNFR1 partitions in lipid rafts, whereas Fas
is excluded from these microdomains. Lipid
rafts are enriched in cholesterol and
caveolin-1. A fraction of TRAF2 localizes in
lipid rafts due to protein-protein interaction
with caveolin-1. Upon receptor engagement,
TNFR1 translocates transiently to lipid rafts
where it associates with TRADD, RIP, and
TRAF2. Lipid rafts serve as platforms where
the TNF-mediated signaling complex accu-
mulates to induce signal transduction events
leading to NF-B activation. NF-B activation
upregulates the expression of antiapoptotic
factors, such as the caspase-8 inhibitor FLIP,
which protects cells from apoptosis. Further-
more, lipid rafts are critical for TNF-medi-
ated TNFR1 and RIP ubiquitylation. Blocking
lipid rafts by MCD or DPPE inhibits ubiquityla-
tion of TNFR1 and RIP, blocks NF-B activa-
tion, and may inhibit the synthesis of survival
factors, such as FLIP, resulting in an in-
creased sensitivity to TNF-mediated apo-
ptosis.
calize with the ganglioside GM1 in microdomains. In and TRAF2 are ubiquitylated in the cholesterol/sphingo-
lipid-enriched membrane microdomains. Interferingaddition, Fas capping and FasL-induced apoptosis were
both ceramide-dependent in Jurkat T cells and hepato- with the structure and composition of membrane micro-
domains provided additional evidence for the crucialcytes, thus suggesting the association of clustered Fas
with microdomains (Cremesti et al., 2001; Grassme et role of lipid rafts. MCD-mediated disruption of lipid rafts
blocked the ubiquitylation of both TNFR1 and RIP, indi-al., 2001a, 2001b). This, however, is at odds with another
study, which showed that lipid raft localization and cap- cating that ubiquitylation is either required for transloca-
tion to microdomains or that ubiquitylation occurs withinping of Fas in Jurkat and HL-60 cells was dependent
on the presence of the ether lipid ET-18-OCH3 (Gajate lipid rafts. To address this question, we specifically in-
hibited the activation-induced recruitment to lipid raftsand Mollinedo, 2001). Yet another report showed that
Fas clustering and FasL-induced apoptosis was inde- without altering the protein composition of lipid rafts by
exogenous addition of DPPE (Legler et al., 2001). DPPE,pendent of lipid rafts in Jurkat and SKW6.4 cells (Alge-
ciras-Schimnich et al., 2002). Our results clearly demon- in contrast to DOPE, treatment of the cells impaired the
modification of both TNFR1 and RIP, indicating thatstrate that FasL-induced signaling complex formation
and apoptosis in HT1080 cells are independent of lipid translocation precedes ubiquitylation and that the addi-
tion of ubiquitin takes place within microdomains (Figurerafts.
The lipid raft’s localization of CD40, another member 5). In addition, upon MCD or DPPE treatment, the
amount of signaling molecules recruited to the engagedof the TNFR family, is less controversial (Hostager et
al., 2000; Kaykas et al., 2001; Pham et al., 2002; Vidalain TNFR1 was reduced (RIP) or inhibited (IKK and IKK),
indicating that lipid rafts are also critical for the assemblyet al., 2000). Upon antibody or CD40L stimulation, TRAF2
and TRAF3 bind to CD40 in lipid rafts. The microdomain and/or the stability of the TNF-induced signaling
complex.integrity is essential for CD40-mediated NF-B activa-
tion since MCD-mediated cholesterol depletion was Ubiquitylation can target proteins for degradation and
may be critical for limiting inflammation by terminatingshown to block the translocation of TRAF molecules to
lipid rafts and hampered their association with CD40 TNF-induced NF-B activation. Lactacystin treatment
resulted in an accumulation of modified protein provid-(Hostager et al., 2000; Vidalain et al., 2000). Moreover,
TRAF2 and TRAF3 were degraded via the proteasome ing evidence that ubiquitylation of TNFR1 and RIP leads
to their degradation via the proteasome (Figure 4). Wepathway after CD40 engagement (Brown et al., 2001),
although the role of lipid rafts in this degradation process cannot, however, exclude that other modifications also
take place in the signaling complex, but the changes inwas not addressed.
The presence of modified forms of TNFR1-associated the apparent molecular weight observed on SDS-PAGE
of TNFR1 and RIP cannot be explained exclusively byRIP in Triton X-100 cell lysates has been recently re-
ported (Chen et al., 2002; Zhang et al., 2000). Our data phosphorylation of the protein since phosphatase treat-
ment did not decrease the amount of modified formsconfirm and extend these observations. In fact, using a
method allowing the isolation of lipid rafts from nonionic observed in the signaling complex (data not shown).
Moreover, no sumoylation could be detected by West-detergent cell extracts, we provide direct evidence that,
upon TNF triggering, TNFR1 and RIP but not TRADD ern blot analysis using sumo-specific Ab (data not
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Antibodiesshown). In this context it is worthy to note that a protein
Rabbit anti-EGFR pAb was from Upstate Biotechnology (Lakerelated to the proteasomal subunit of the 26S protea-
Placid, NY). Rabbit anti-Fas pAb C20, mouse anti-TNFR1 mAb H-5,some, termed 55.11, was found to bind to the intracellu-
rabbit anti-TRAF2 pAb C20, rabbit anti-Fyn pAb FYN3, and rabbit
lar domain of TNFR1 (Boldin et al., 1995). Furthermore, anti-HA pAb were from Santa Cruz Biotechnology (Santa Cruz, CA).
the ubiquitin ligases Cbl and Nedd4 were shown to parti- Rabbit anti-phospho-IB pAb and rabbit anti-total-IB pAb were
tion in lipid rafts upon IgE triggering (Lafont and Simons, from New England BioLabs (Allschwil, Switzerland). Rabbit anti-
caveolin-1 pAb, mouse anti-FADD mAb, mouse anti-TRADD mAb,2001). Recently, it has also been shown that TRAF6
mouse anti-IKK mAb, and mouse anti-RIP mAb were from Trans-(which is not recruited to TNFR1) and TRAF2 function
duction Laboratories (Lexington, KY). Mouse anti-caspase-8 mAbtogether with Ubc13/Uev1A to catalyze the ligation of
was from MBL (Nunningen, Switzerland). Mouse anti-ubiquitin mAb
unique polyubiquitin chains (Deng et al., 2000; Wang et FK2 was from Affiniti Research Products Ltd (Exeter, United King-
al., 2001). To determine whether TRAF2 may act as an dom). Mouse anti-IKK mAb was from Pharmingen (BD, Erembode-
E3 ubiquitin ligase in the ubiquitylation of TNFR1 and gem, Belgium). CTxHRP was from Sigma (Buchs, Switzerland). HRP-
conjugated goat ant-mouse IgG1, IgG2a, and IgG2b Ab were fromRIP, we transfected HT1080 cells with a modified TRAF2
Southern Biotechnology Associates (Birmingham, AL). HRP-conju-whose RING finger domain was deleted (Devin et al.,
gated goat anti-rabbit IgG Ab was from Jackson ImmunoResearch2000; Rothe et al., 1995). Overexpression of this modi-
(West Grove, PA).fied TRAF2 had no apparent effect on the ubiquitylation
of TNFR1 and RIP (data not shown), indicating that Ligands, Lipids, and Chemicals
TRAF2 is probably not the ubiquitin ligase responsible Human recombinant Flag-tagged TNF and Flag-tagged Mega-FasL
for the modification of TNFR1 and RIP. To gain further were from Apotech (Epalinges, Switzerland). Dipalmitoyl-phosphati-
dylethanolamine (DPPE) and dioleoyl-phosphatidylethanolamineinformation on ubiquitylation, we overexpressed various
(DOPE) were purchased from Sigma, and liposomes at 2 mg/mlmyc-tagged RIP mutants in HT1080 cells. Following
were generated in PBS containing 30 mM -octyl-glucopyranosidestimulation and immunoprecipitation of engaged TNFR1
(Fluka, Buchs, Switzerland) and used at 50 g/ml in serum-free
signaling complex, no significant change of TNFR1 and medium as described (Legler et al., 2001). Methyl--cyclodextrin
RIP modification could be observed by Western blot (Sigma) was used at 25 mM final concentration. To block protea-
analysis using anti-myc, anti-TNFR1, or anti-RIP anti- some-mediated protein degradation, cells were incubated in me-
dium containing 40 M lactacystin (Affiniti Research Products Ltd)bodies in cells overexpressing the K45R mutant and a
for 30 min at 37C prior to stimulation as described (Shen et al.,mutant lacking the kinase domain (KD) (Holler et al.,
1997). Cells were labeled with 14C cholesterol as described pre-2000; Ting et al., 1996), indicating that, at least for RIP,
viously (Legler et al., 2001), and the cholesterol distribution wasmore than one lysine is ubiquitylated upon TNF stimu-
analyzed in Triton X-100 soluble and insoluble fractions.
lation. In HT1080 cells overexpressing a mutant lacking
the death domain (DD), no significant alteration of the Lipid Raft Isolation and Western Blotting
modification of endogenous TNFR1 and RIP was ob- Lipid rafts were isolated by sucrose density gradient centrifugation
essentially as described (Zhang et al., 1998). In brief, subconfluentserved, whereas the recruitment of RIP(DD) to engaged
HT1080 cells from two 15 cm culture dishes were lysed on ice forTNFR1 was impaired. Further investigations such as
20 min in 2 ml of MNX buffer (1% Triton X-100 in 25 mM MES, 150site-directed mutations of the potential ubiquitylated ly-
mM NaCl [pH 6.5]) supplemented with 10 g/ml benzamidine, 2
sine residues or ubiquitylation regulatory regions of the
g/ml antipain, and 1 g/ml leupeptin, and homogenized (10
proteins are necessary to gain more information about strokes) with a loose-fitting glass dounce homogenizer (Polylabo,
the functional significance of this structural processing Illkirch, France). The homogenates were mixed with 2 ml 90% su-
crose made with MN buffer and placed on the bottom of a centrifugeof both proteins.
tube. The samples were then overlaid with 4 ml of 35% sucrose andIn conclusion, we demonstrate that lipid rafts serve
4 ml of 5% sucrose and centrifugated at 175,000 g in a Centrikonas platforms for TNF-mediated signaling by recruiting
T-2070 centrifuge (Kontron Analytics, Zu¨rich, Switzerland) for 16 hr
adaptor molecules, such as TRADD and TRAF2, and at 4C. One milliliter fractions were collected from the top of the
kinases, like RIP and the IKK complex, to microdomains gradient and analyzed by Western blotting. The pellet present at
leading to NF-B activation. In addition, these microdo- the bottom of the gradient was sonicated in 1 ml of MNX.
Alternatively, Triton X-100 insoluble raft fractions were preparedmains play a critical role in the specific modification of
essentially as described (Legler et al., 2001). In brief, cells (2  106 )TNFR1 and RIP by ubiquitin. Disruption of lipid rafts
were lysed on ice for 20 min in 200 l of MNX buffer. The cell lysateby cholesterol depletion or blocking activation-induced
was homogenized as above and spun at 500 g for 7 min at 4C; the
recruitment of signaling molecules to lipid rafts by DPPE nuclear pellet was washed sequentially in MNX and 0.5 % Brij 78
inhibits the triggering of the NF-B pathway and there- in PBS. The postnuclear supernatant was centrifuged at 100,000 g
fore induces the switch of TNF-mediated responses for 1 hr at 4C. The lipid raft fraction in the pellet was resuspended
in 200 l of 0.5 % Brij 78; nonsoluble material was removed by antoward apoptosis.
additional centrifugation. The 100,000 g supernatant is referred to
as the Triton X-100 soluble fraction containing the phospholipidExperimental Procedures
membrane and cytosolic fraction.
Proteins from total cell lysates and immunoprecipitates were re-Cells
solved by SDS-PAGE and transferred to Protran nitrocellulose mem-Human fibrosarcoma cells HT1080, wild-type and IB mutant (Mi-
branes (Schleicher & Schuell, Dassel, Germany). Nonspecific bind-cheau et al., 2001), were cultured in high glucose Dulbecco’s modi-
ing sites were blocked by incubation in PBS containing 0.05%fied Eagle’s medium supplemented with 10% fetal calf serum, 5 g/
Tween 20 and 5% dry milk. Immunoblots were then incubated withml penicillin, 5g/ml streptomycin, and 10g/ml neomycin (GIBCO-
specific primary Ab followed by HRP-conjugated secondary Ab andBRL Life Technologies Inc., Paisley, United Kingdom) and grown in
were developed by the enhanced chemiluminescence method ac-5% CO2 at 37C. HT1080 cells were stably transfected with wild-
cording to the manufacturer’s protocol (Pierce, Rockford, IL).type TRAF2 and TRAF2 lacking the RING finger domain (TRAF287-501
[Devin et al., 2000], kindly provided by H. Wajant), or mutants of
Receptor-Induced Signaling Complex AnalysisRIP (K45R, KD, DD [Ting et al., 1996]). Alternatively, cells were
A total of 108 HT1080 cells in 1 ml of medium were stimulated withtransiently tranfected using the calcium phosphate method with a
HA-tagged ubiquitin (Treier et al., 1994) (kindly provided by W. Krek). 2 g/ml of TNF or FasL for the indicated times at 37C, washed
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with cold PBS, lysed in 4 ml of MNX buffer, and subjected to lipid sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem.
275, 17221–17224.raft isolation. To immunoprecipitate the total amount of receptor,
5  107 cells were lysed in MNX, the ligand was added, and the Brown, K.D., Hostager, B.S., and Bishop, G.A. (2001). Differential
lysate was fractionated. Soluble and lipid raft fractions were pre- signaling and tumor necrosis factor receptor-associated factor
cleared, and the signaling complex was immunoprecipitated over- (TRAF) degradation mediated by CD40 and the Epstein-Barr virus
night at 4C with anti-Flag M2-agarose beads (Sigma) Alternatively, oncoprotein latent membrane protein 1 (LMP1). J. Exp. Med. 193,
ubiquitylated proteins of Triton X-100 soluble and insoluble raft 943–954.
fractions were immunoprecipitated using an anti-ubiquitin mAb and
Budd, R.C. (2001). Activation-induced cell death. Curr. Opin. Immu-
protein G Sepharose beads. Beads were washed four times with
nol. 13, 356–362.
1% Triton X-100 or 0.5% Brij 78, respectively. Where indicated, the
Chen, G., Cao, P., and Goeddel, D.V. (2002). TNF-induced recruit-TNF signaling complex was dissociated in 50 l of PBS containing
ment and activation of the IKK complex require Cdc37 and Hsp90.1% SDS by boiling for 10 min and diluted 20-fold with lysis buffer
Mol. Cell 9, 401–410.before it was subjected to a second immunoprecipitation using 10
Cottin, V., Doan, J.E., and Riches, D.W. (2002). Restricted localiza-g/ml of an anti-ubiquitin Ab.
tion of the TNF receptor CD120a to lipid rafts: a novel role for the
death domain. J. Immunol. 168, 4095–4102.NF-B Activation
Cremesti, A., Paris, F., Grassme, H., Holler, N., Tschopp, J., Fuks,Cells were treated or not with MCD, DPPE, or DOPE for 30 min,
Z., Gulbins, E., and Kolesnick, R. (2001). Ceramide enables Fas towashed, and stimulated with 0.2 g/ml TNF or FasL for 2 min.
cap and kill. J. Biol. Chem. 276, 23954–23961.Cells were immediately washed with cold PBS, lysed, and subjected
to Western blot analysis to detect phosphorylated IB. Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaugh-
ter, C., Pickart, C., and Chen, Z.J. (2000). Activation of the IB kinase
complex by TRAF6 requires a dimeric ubiquitin-conjugating enzymeCell Death and Viability Assay
complex and a unique polyubiquitin chain. Cell 103, 351–361.Cells were treated or not with MCD, DPPE, or DOPE and stimulated
for 90 min with 10 g/ml of TNF, 1 g/ml of FasL, or anti-TNFR2 Devin, A., Cook, A., Lin, Y., Rodriguez, Y., Kelliher, M., and Liu, Z.
(UTR1) Ab. Cells were extensively washed, seeded at 1.5  104 (2000). The distinct roles of TRAF2 and RIP in IKK activation by TNF-
cells/well in 96-well microtiter plates, and cultured for 36 hr, and R1: TRAF2 recruits IKK to TNFR1 while RIP mediates IKK activation.
viable cells were stained with methylene blue and quantified by Immunity 12, 419–429.
measuring the optical density at 630 nm. Dhein, J., Daniel, P.T., Trauth, B.C., Oehm, A., Moller, P., and Kram-
mer, P.H. (1992). Induction of apoptosis by monoclonal antibody
Acknowledgments anti-APO-1 class switch variants is dependent on cross-linking of
APO-1 cell surface antigens. J. Immunol. 149, 3166–3173.
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